Upload File

supplementary figure s1 a) b)

2
Supplementary Figure S1 A) B) Overall survival (A) and time to progression (B) of the entire study population. Kaplan-Meier curves of 158 consecutive myeloma patients are depicted for overall survival and time to progression. X-axis in months, Y-axis in percent survival. (A) The median overall survival of the study population was 72 months. 42 patients have died. (B) Median time to progression was 39 months. 70 patients had a fist progression of the disease. 0 20 40 60 80 100 0 20 40 60 80 100 0 20 40 60 80 0 20 40 60 80 100

Upload: buckminster-dixon

Post on 02-Jan-2016

26 views

Category:

Documents


2 download

Report

DESCRIPTION

Supplementary Figure S1 A) B). - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Supplementary Figure S1 A) B)

Supplementary Figure S1

A) B)

Overall survival (A) and time to progression (B) of the entire study population. Kaplan-Meier curves of 158 consecutive myeloma patients are depicted for overall survival and time to progression. X-axis in months, Y-axis in percent survival. (A) The median overall survival of the study population was 72 months. 42 patients have died. (B) Median time to progression was 39 months. 70 patients had a fist progression of the disease.

0 20 40 60 80 1000

20

40

60

80

100

0 20 40 60 800

20

40

60

80

100

Page 2: Supplementary Figure S1 A) B)

Supplementary Figure S2

Distribution of the number of circulating CD34+ cells at the day of stem cell collection from all 158 patients in this study. Waterfall diagram presentation of the number of CD34+ cells from all patients. The value of 100’000 CD34+ cells/ml separated the 69 super mobilizers (upper bars) from the 89 normal mobilizers (lower bars).

normal mobilizers bad mobilizers0

100000

200000

300000

400000

500000

600000

super mobilizersn normal mobilizers


Supplementary Figure S1. Cladogram for the …...Supplementary Figure S1. Cladogram for the Poaceae. Based on the combined Bayesian phylogenetic analysis of molecular and morphological

Supplementary information Supplemental Figure Legends · Supplementary information Supplemental Figure Legends Fig S1. Fin Morphogenesis. ... ADP-ribosylation factor-like protein

Supplementary Informationdm5migu4zj3pb.cloudfront.net/manuscripts/42000/42285/JCI42285s… · Supplementary Information Figure S1. Characterization of TAK1 expression. (A) Sections

Supplementary Figure Legends Figure S1. fileSupplementary Figure Legends Figure S1. Group statistic maps for somatomotor connectivity of the TBI sub-groups. Seeds were placed at the

Supplementary materials Web viewSupplementary materials Supplementary Figure S1. The flowchart for obtaining the mRNA-miRNA co-expression network and experimental validation Supplementary

Supplementary Figure S1: Schematic depicting the nanotomy … · 2012-05-15 · 1 Supplementary Figure S1: Schematic depicting the nanotomy process. (a) An image (taken via Nikon

Supplementary Figure S1

Supplementary Figures Figure S1 CD8 checkpoint …Supplementary Figures Figure S1 CD8 checkpoint blockade promotes vascular regeneration and function in DIO mice after injury. (A)

Ve č erek et al. Supplementary Figure S1

Supplementary figure S1

Supplementary S1

Supplementary figure S1

Supplementary Figure S1 A B MTT MTT LDH activity 1100 · A B MTT LDH activity C. Supplementary Figure S2. Supplementary Figure S3 A B 0 2 4 6 8 relative chemotactic index - + + +

SUPPLEMENTARY INFORMATION - images.nature.com€¦ · DOI: 10.1038/NCHEM.1570 SUPPLEMENTARY INFORMATION 2 Supplementary Figure S1: Isothermal Titration Calorimetry (ITC) control experiments

SUPPLEMENTARY FIGURES AND TABLES€¦ ·  · 2016-06-14 ncotarget Supplementary Materials 2015 SUPPLEMENTARY FIGURES AND TABLES Supplementary Figure S1: A. The flowchart represents

media.nature.com · 1 Supplementary Materials Supplementary Table S1 Supplementary Table S2 Supplementary Table S3 Supplementary Figure S1 Supplementary Figure S2 Supplementary Figure

Supplementary Figure Legends Figure S1....Supplementary Figure Legends Figure S1. Group statistic maps for somatomotor connectivity of the TBI sub-groups. Seeds were placed at the

SUPPLEMENTARY FIGURE LEGENDS Figure S1. TOFU-4::GFP and TOFU …genesdev.cshlp.org/content/suppl/2018/12/19/gad.319293... · 2018. 12. 19. · Weng et al. SUPPLEMENTARY FIGURE LEGENDS

SUPPLEMENTARY RESULTS Figure S1. Mutant p53 Promotes ...genesdev.cshlp.org/content/suppl/2015/06/12/gad.263202.115.DC1/Supp... · SUPPLEMENTARY RESULTS Figure S1. Mutant p53 Promotes

Supplementary Figure S1 | Fabrication of a lucius prism ... · Supplementary Figure S1 | Fabrication of a lucius prism array sheet. a, A schematic on a lucius prism. b, An SEM image

SUPPLEMENTARY INFORMATIONgeodynamics.usc.edu/~becker/preprints/fb10_supp.pdfSupplementary Figures Supplementary Figure S1. Comparison of velocity anomaly maps of tomographic models

Supplementary Figure S1. Schematic illustration of the 4 ... · Supplementary Figure S1. Schematic illustration of the 4 ... The addition of a strong tetanus to s2i ending 15 min

Supplementary Figure S1. The EJC is required for ...genesdev.cshlp.org/content/suppl/2014/07/29/gad.245738.114.DC1/Supplemental_Material.pdfSupplementary Figure S1. The EJC is required

CaltechAUTHORS - Supplementary Figure 1authors.library.caltech.edu/71504/10/nmeth.4100-S1.pdf · 2017. 1. 3. · Supplementary Figure 7 Significance of Global Score predictions. We

Figure S1 - CaltechAUTHORSauthors.library.caltech.edu/17419/2/1.pdf · Supplementary Figure Legends Figure S1. A, Drosophila melanogaster Pumilio amino acid sequence with Q/Ns highlighted

Supplementary Information Supplementary Figure S1. Phenotypic … · 2013-02-05 · 2 Supplementary Figures and Legends Fig.S1 Supplementary Figure S1. Phenotypic comparison of the

SUPPELEMNTARY TABLE 1 · Web view8 Supplementary Figure S2 9 Supplementary Figure S3 10 SUPPLEMENTARY METHODS 13 References 14 GERAD1 author list Supplementary Table S1. Association

Supplementary Fig. S1 Supplementary Figure S1. The co-expression profile among ALDH activity, mem Grp78 and Glut3 in SAS Sphere cells and cisplatin-resistant

images.nature.com · Web viewSupplementary Figure 7 Supplementary Figure 3 Supplementary Figure 1 Supplementary Materials Supplementary Figures S1-S7 Supplementary Tables S1-S7 Clinical

Supplementary Figure S1 - Clinical Cancer Research · Supplementary Figure S1 Antibody responses against CpG 7909 in patients vaccinated with NY-ESO-1 p157-65/Montanide and CpG (LUD

Supplementary File 1, Figures S1 to S11 Figure legends

SUPPLEMENTARY INFORMATION - Geophysicsgeophysics.wustl.edu/seminar/2010_Tauzin_NatureGeo_SOM.pdf · SUPPLEMENTARY INFORMATION doi: 10.1038/ngeo969 2 Supplementary Figure S1 Global

Supplementary Figure S1. Characterization of rabbit ... Supplementary Figure S1. Characterization of rabbit polyclonal anti-DCLK antibody. (A) Immunoblotting of COS7 cells transfected

Supplementary Figure S1 - ncbi.nlm.nih.gov

Supple Figure S1 - rsc.org · Supplementary Figure S1. (A) Categories of intracellular locations in Supplementary Table S1A. The numbers of proteins in various locations were compared